VENU CEO Roth sells 8,116 shares, keeps 10.3M stake – Form 4
Rhea-AI Filing Summary
Venu Holding Corp. (VENU) – Form 4 insider filing
CEO & Chairman Jay W. Roth reported four open-market sales of VENU common stock on 3 July 2025 and 7 July 2025:
- Direct: 2,723 sh @ $12.93 and 3,656 sh @ $12.56
- Indirect (KMR Living Trust): 741 sh @ $12.93 and 996 sh @ $12.56
Total shares sold: 8,116 (≈0.07 % of combined holdings).
Post-sale ownership:
- Direct – 9,261,649 sh
- Indirect (trust) – 1,004,350 sh
No derivative transactions were reported. The filing was signed by attorney-in-fact on 8 July 2025. The modest scale relative to the insider’s remaining 10.3 million-share stake suggests routine portfolio management rather than a strategic exit, yet investors often view any C-suite sales as a potential sentiment signal.
Positive
- None.
Negative
- CEO insider sale: Disposed of 8,116 shares, which can be interpreted as a mild negative sentiment signal despite being a small percentage of holdings.
Insights
TL;DR: CEO sold 8,116 shares (~$103k), keeps 10.3 M stake; minimal impact.
The disposition represents under 0.1 % of Mr. Roth’s ownership and does not materially change insider alignment. Average sale price of $12.75 gives a rough cash value of ~$103 k, immaterial against VENU’s market cap (not provided in filing). No accompanying option exercise, 10b5-1 notation, or strategic context is disclosed. While any leadership-level sale can pressure sentiment short term, the tiny percentage and continued >10 M-share holding point to routine diversification. I classify it as neutral-to-slightly negative for sentiment, not fundamental.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 3,656 | $12.56 | $46K |
| Sale | Common Stock | 996 | $12.56 | $13K |
| Sale | Common Stock | 2,723 | $12.93 | $35K |
| Sale | Common Stock | 741 | $12.93 | $10K |
Footnotes (1)
- F1. These shares of common stock, par value $0.001 per share (the "Common Stock"), are owned directly by the KMR Living Trust dated November 19, 2012 (the "KMR Living Trust"), of which Mr. Jay W. Roth is a trustee. As a trustee, Mr. Roth is deemed to have indirect beneficial ownership of the shares held by the KMR Living Trust.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What is Jay W. Roth’s remaining stake in Venu Holding Corp. after the sales?
Did the Form 4 report any option exercises or derivative transactions?
Is the transaction part of a Rule 10b5-1 trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.